» Articles » PMID: 31143185

Mouse Models of Heterologous Flavivirus Immunity: A Role for Cross-Reactive T Cells

Overview
Journal Front Immunol
Date 2019 May 31
PMID 31143185
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Most of the world is at risk of being infected with a flavivirus such as dengue virus, West Nile virus, yellow fever virus, Japanese encephalitis virus, tick-borne encephalitis virus, and Zika virus, significantly impacting millions of lives. Importantly, many of these genetically similar viruses co-circulate within the same geographic regions, making it likely for individuals living in areas of high flavivirus endemicity to be infected with multiple flaviviruses during their lifetime. Following a flavivirus infection, a robust T cell response is generated and the memory recall of this response has been demonstrated to provide long-lasting immunity, protecting against reinfection with the same pathogen. However, multiple studies have shown that this flavivirus specific T cell response can be cross-reactive and active during heterologous flavivirus infection, leading to the question: It has been proposed that in some cases unfavorable disease outcomes may be caused by lower avidity cross-reactive memory T cells generated during a primary flavivirus infection that preferentially expand during a secondary heterologous infection and function sub optimally against the new pathogen. While in other cases, these cross-reactive cells still have the potential to facilitate cross-protection. In this review, we focus on cross-reactive T cell responses to flaviviruses and the concepts and consequences of T cell cross-reactivity, with particular emphasis linking data generated using murine models to our new understanding of disease outcomes following heterologous flavivirus infection.

Citing Articles

Human coronavirus OC43-elicited CD4 T cells protect against SARS-CoV-2 in HLA transgenic mice.

Alves R, Timis J, Miller R, Valentine K, Pinto P, Gonzalez A Nat Commun. 2024; 15(1):787.

PMID: 38278784 PMC: 10817949. DOI: 10.1038/s41467-024-45043-2.


Insights into Zika Virus Pathogenesis and Potential Therapeutic Strategies.

Camacho-Concha N, Santana-Roman M, Sanchez N, Velasco I, Pando-Robles V, Pedraza-Alva G Biomedicines. 2023; 11(12).

PMID: 38137537 PMC: 10741857. DOI: 10.3390/biomedicines11123316.


Primary infection with Zika virus provides one-way heterologous protection against Spondweni virus infection in rhesus macaques.

Jaeger A, Crooks C, Weiler A, Bliss M, Rybarczyk S, Richardson A Sci Adv. 2023; 9(26):eadg3444.

PMID: 37390207 PMC: 10313173. DOI: 10.1126/sciadv.adg3444.


Cellular T-cell immune response profiling by tetravalent dengue subunit vaccine (DSV4) candidate in mice.

Aggarwal C, Ramasamy V, Garg A, Shukla R, Khanna N Front Immunol. 2023; 14:1128784.

PMID: 36926350 PMC: 10011089. DOI: 10.3389/fimmu.2023.1128784.


West Nile Virus Vaccination Protects against Usutu Virus Disease in Mice.

Salgado R, Hawks S, Frere F, Vazquez A, Huang C, Duggal N Viruses. 2021; 13(12).

PMID: 34960621 PMC: 8704473. DOI: 10.3390/v13122352.


References
1.
Arstila T, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P . A direct estimate of the human alphabeta T cell receptor diversity. Science. 1999; 286(5441):958-61. DOI: 10.1126/science.286.5441.958. View

2.
Haanen J, Wolkers M, Kruisbeek A, Schumacher T . Selective expansion of cross-reactive CD8(+) memory T cells by viral variants. J Exp Med. 1999; 190(9):1319-28. PMC: 2195685. DOI: 10.1084/jem.190.9.1319. View

3.
Selin L, Lin M, Kraemer K, Pardoll D, Schneck J, Varga S . Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity. 2000; 11(6):733-42. DOI: 10.1016/s1074-7613(00)80147-8. View

4.
Casrouge A, Beaudoing E, Dalle S, Pannetier C, Kanellopoulos J, Kourilsky P . Size estimate of the alpha beta TCR repertoire of naive mouse splenocytes. J Immunol. 2000; 164(11):5782-7. DOI: 10.4049/jimmunol.164.11.5782. View

5.
Surh C, Sprent J . Homeostatic T cell proliferation: how far can T cells be activated to self-ligands?. J Exp Med. 2000; 192(4):F9-F14. PMC: 2193242. DOI: 10.1084/jem.192.4.f9. View